KLA Ranks 182nd in Trading Volume as Institutions Buy, Insiders Sell Shares

On August 27, 2025, KLA (KLAC) closed with a 0.09% gain, trading on a volume of $0.47 billion, a 35.02% decline from the prior day’s activity. The stock ranked 182nd in trading volume among equities. Institutional and insider activity dominated headlines, with multiple investment firms adjusting their positions in KLA shares. Synovus Financial Corp increased its stake by 14.3%, acquiring additional shares valued at $5.58 million. Other institutional investors, including T. Rowe Price and Integrated Wealth Concepts, also boosted holdings, while entities like BNP Paribas and Northern Trust Corp reduced their positions. Insider transactions included notable sales by KLA’s EVP Brian Lorig and CEO Richard Wallace, raising concerns about potential short-term sentiment shifts.

The company reported robust quarterly results, with $3.17 billion in revenue and $9.38 earnings per share, surpassing estimates. KLA’s board approved a $5 billion stock repurchase program, signaling confidence in its valuation. A $1.90 quarterly dividend was declared, maintaining a payout ratio of 25.01%. Analysts have varied in their assessments, with Morgan Stanley and Raymond James upgrading price targets, while Goldman Sachs and TD Securities issued neutral or cautious outlooks. Despite mixed institutional activity and insider selling, KLA’s fundamentals remain strong, supported by its 23.6% year-over-year revenue growth and a 33.41% net margin.

Backtest results indicate no direct correlation between recent KLA price movements and the unrelated news items provided. The stock’s 0.09% gain on August 27 aligns with broader market trends but lacks clear linkage to the cited developments in smart eyewear, health products, or unrelated legal cases.